OpenScience.ink

3 weeks ago • Clinics and practice

Muscle-Protecting Fat Loss in People with Obesity-Related Type 2 Diabetes During 12 Months of Metformin TreatmentMyoprotective Fat-Loss Phenotypes in Obesity-Associated Type 2 Diabetes: A 12-Month Real-World Cohort Study of Metformin-Based Treatment Regimens.

Article

4 weeks ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

Updating Worldwide Obesity Guidelines by Combining Evidence, Fairness, and Personalized Approaches (2014-2026)Rethinking Global Obesity Guidelines: Integrating Evidence, Equity and Precision (2014-2026).

Article

1 month ago • Internal and emergency medicine

Oral semaglutide compared to DPP-4 inhibitors for lowering risk of thinking problems in older adults with heart failure and obesityOral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity.

Article

2 days ago • JCEM case reports

Glucagon-like peptide-1 receptor drugs as add-on treatment for hard-to-treat high blood fat after repeated pancreas inflammationGlucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.

Case Reports

4 days ago • Nephron

Metabolic and kidney effects of using liraglutide followed by setmelanotide in Bardet-Biedl Syndrome: a real-life case and reviewSequential liraglutide and setmelanotide therapy in Bardet-Biedl Syndrome: metabolic and renal outcomes in a real-world case report and literature review.

Case Reports

1 week ago • Cureus

Tirzepatide treatment linked to broad metabolic improvements in an active duty service memberTirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report.

Case Reports

2 weeks ago • Cureus

Possible Two-Phase Allergic Reaction After First Dose of Tirzepatide: A Case Report and Summary of Similar ReactionsSuspected Biphasic Anaphylaxis Following the First Known Dose of Tirzepatide: A Case Report and Brief Review of Reported Hypersensitivity Reactions.

Case Reports

2 weeks ago • Cureus

Retatrutide from Online Sources May Worsen Diabetic Ketoacidosis in a Type 1 Diabetes Patient with Shigella InfectionOnline-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis.

Case Reports

3 weeks ago • Cureus

When Weight Loss Becomes Harmful: Ketoacidosis Linked to Tirzepatide in a Woman Without DiabetesWhen Weight Loss Turns Dangerous: A Case Report of Tirzepatide-Induced Ketoacidosis in a Non-diabetic Woman.

Case Reports

3 weeks ago • Cureus

Severe Dumping Syndrome and Ongoing Obesity After Gastric Bypass with Missing Stomach Pouch, Improved by Tirzepatide: A Case ReportSevere Dumping and Persistent Obesity in a Post-Roux-en-Y Gastric Bypass Patient With a Non-discernible Gastric Pouch and Symptomatic Improvement on Tirzepatide: A Case Report.

Case Reports

1 month ago • Cureus

Severe Stomach Problems After Restarting Semaglutide at Regular Dose Following a Break During RamadanSevere Gastrointestinal Intolerance After Resuming Maintenance-Dose Semaglutide Following Ramadan-Related Treatment Interruption: A Case Report.

Case Reports

yesterday • Cardiovascular drugs and therapy

Liraglutide may reduce atrial fibrillation by boosting fat tissue signals around the heartLiraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue.

Article

yesterday • Diabetes, obesity & metabolism

How Safe and Effective BGM0504 Is and How It Acts in the Body in Overweight or Obese Chinese Adults Without DiabetesEffectiveness, Safety and Pharmacokinetics of BGM0504, a Dual GLP-1/GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.

Article

yesterday • Diabetes, obesity & metabolism

How adults and children with obesity stick to GLP-1 receptor agonist treatments over timeReal-World Adherence Trajectories of GLP-1 Receptor Agonists Among Adults and Paediatric Patients With Obesity.

Article

yesterday • Therapeutic advances in reproductive health

Obesity and weight-loss treatments using GLP-1 in patients cared for by women's health doctorsThe clinical relevance of obesity and glucagon-like peptide-1-based therapies for chronic weight management in patients treated by obstetrician-gynecologists and gynecologists: A non-systematic narrative review.

Article

2 days ago • Drug and alcohol dependence reports

Treating opioid and alcohol use disorders together in the US from 1960 to 2026 during the rise of GLP-1 based therapiesCo-treating opioid and alcohol use disorders in the United States, 1960-2026: A historical policy review in the glucagon-like peptide-1 (GLP-1) era.

Article

2 days ago • Diabetes, obesity & metabolism

Heart and kidney benefits and safety of Finerenone, SGLT2 inhibitors, Semaglutide, and their combination in diabetic kidney diseaseComparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease.

Article

2 days ago • AIDS (London, England)

Semaglutide’s effects on hidden heart health issues in people with HIVEffects of semaglutide on subclinical cardiovascular health in people with HIV.

Article

3 days ago • Diabetes care

How India Makes New Diabetes Medicines Affordable and Available for Other CountriesMaking Modern Diabetes Medications Affordable and Accessible: Lessons From India for Other Countries.

Article

3 days ago • Lung

How GLP-1 Receptor Agonists May Help Pulmonary Hypertension: Mechanisms, Animal Studies, and Unknowns in Human TreatmentGLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps.

Article

3 days ago • Journal of psychopharmacology (Oxford, England)

Adding GLP-1 receptor drugs to reduce heart and metabolism risks in patients taking antipsychotics: A review of clinical trialsAdjunctive GLP-1 receptor agonists for cardiometabolic risk in antipsychotic-treated patients: A GRADE-assessed meta-analysis of randomized trials.

Article

3 days ago • Cureus

The Increasing Influence of Oral GLP-1 Drugs on UK Obesity PoliciesAssessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom.

Editorial

4 days ago • Cureus

Semaglutide use and mood disorders in women with multiple hormonal and metabolic problemsInvestigating the Association Between Semaglutide Use and Mood Disorders in Polyendocrine Metabolic Ovarian Syndrome: A Retrospective Cohort Study.

Article

5 days ago • Experimental gerontology

GLP-1 receptor drugs, aging-related gene changes, and possible lifespan extension with medicineGLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.

Article

5 days ago • Expert review of respiratory medicine

Links Between GLP-1 Therapy and Asthma Outcomes in People with ObesityAssociation of GLP-1-based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study.

Article

5 days ago • Diabetes, obesity & metabolism

Reducing Mealtime Insulin Using GLP-1 Medicines in Type 2 Diabetes Patients on Multiple Daily Insulin Shots: A Review of Clinical TrialsGLP-1 Receptor Agonist-Based Prandial Insulin De-Intensification in Outpatients With Type 2 Diabetes Receiving Basal-Bolus Insulin Therapy or Multiple Daily Injections: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Article

5 days ago • Diabetes, obesity & metabolism

Mental Health Safety of GLP-1 and Dual GIP/GLP-1 Treatments in Obese AdolescentsPsychiatric Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adolescents With Obesity.

Article

5 days ago • Problemy endokrinologii

Hair Loss During Obesity Treatment: Current Challenges and Possible Solutions[Hair loss during treatment of obesity: current state of the problem and potential solutions].

English Abstract

6 days ago • Cureus

How Tirzepatide and Semaglutide Compare in Effectiveness and Safety for Treating ObesityComparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review.

Article

1 week ago • Cureus

GLP-1 and GIP/GLP-1 Receptor Drugs for Weight Gain Caused by Antipsychotic Medicines: A ReviewGLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review.

Article

← prevpage 12 of 14next →

GLP-1 Therapies Research Papers